Prelude Capital Management’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding NFYS.WS
SCM
PAMP
RCM
GAM
CCM
PC
AA
AA
SCM
Prelude Capital Management's NFYS.WS Position: Q3 2023 in Review
Prelude Capital Management sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2023, closing a stake of 306,250 shares — an estimated $15.3K sold.
Prelude Capital Management first reported a position in NFYS.WS in Q1 2022 and held it in 6 quarters. The position peaked at $86K in Q1 2022. 36 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2023.
- Prelude Capital Management reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2023 after selling out during the quarter.
- Prelude Capital Management sold 306,250 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2023, an estimated $15.3K.
- Prelude Capital Management first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 6 quarters.
- Prelude Capital Management's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $86K in Q1 2022.
- 36 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2023.
Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.